Results 61 to 70 of about 33,657 (222)

Acceptability of the dengue vaccination among parents in urban poor communities of Quezon City, Philippines before and after vaccine suspension

open access: yesBMC Research Notes, 2018
Objective The study aims to illustrate the acceptability of the dengue vaccine before and after the dengue vaccination suspension in urban poor communities in Quezon City, Philippines.
Ezra M. Valido   +2 more
doaj   +1 more source

Decentralisation of the Healthcare Systems and the Functioning of Public Health Programmes in Single‐Party States: A Systematic Review

open access: yesThe International Journal of Health Planning and Management, EarlyView.
ABSTRACT Introduction Decentralisation is the transfer of authority from central to local governments, involving shared responsibilities in planning, management, and decision‐making. In public health, decentralisation might help improve service delivery by allowing local authorities to tailor interventions to the specific needs of diverse ...
Phonevilay Viphonephom   +3 more
wiley   +1 more source

17‐epi‐Melianodiol, a new protolimonoid from Melia azedarach fruits, exhibits larvicidal activity and is associated with oxidative imbalance and midgut epithelial damage in Aedes aegypti larvae

open access: yesPest Management Science, EarlyView.
The bio‐guided phytochemical study resulted in the new compound 17‐epi‐melianodiol. The compound eliminated 100% of Aedes aegypti larvae at 100 ppm, causing pronounced morphological changes, cuticular damage, and extensive vacuolization. Abstract BACKGROUND In Brazil, Aedes aegypti is the primary vector of arboviruses such as dengue, chikungunya ...
Kethleen Duarte Crespo Soares   +8 more
wiley   +1 more source

Dengue vaccine: a key for prevention

open access: yesExpert Review of Vaccines, 2020
Dengue infection is the most important mosquito-borne viral disease in the world. Most mosquito control methods currently available for public health use are not very efficacious. Dengue vaccine is required to control dengue diseases in the future through the use of a safe and effective vaccine.This review covered dengue vaccine development and ...
Usa, Thisyakorn, Terapong, Tantawichien
openaire   +2 more sources

Knowledge, acceptance and willingness to pay for Dengue vaccine in Yogyakarta and Jakarta

open access: yesEpidemiology, Biostatistics and Public Health, 2023
Despite the fact that Dengue Hemorrhagic Fever (DHF) is one of diseases with the highest incidence rate in Indonesia, its prevention strategies remain ineffective. One of the most cost-effective strategies to prevent DHF is through vaccination.
Woro Supadmi   +3 more
doaj   +1 more source

Diarrhea and dengue control in rural primary schools in Colombia: study protocol for a randomized controlled trial. [PDF]

open access: yes, 2012
BACKGROUND: Diarrheal diseases and dengue fever are major global health problems. Where provision of clean water is inadequate, water storage is crucial.
Vargas Sandra   +36 more
core   +1 more source

Maltase 1 regulates DENV2 infection and life history in Aedes aegypti

open access: yesInsect Science, EarlyView.
Our study employed CRISPR/Cas9 to generate a MAL1 knockout strain of Aedes aegypti, demonstrating that the absence of MAL1 significantly suppresses DENV2 replication in the midgut and impairs viral transmission. The mutation also altered life‐history (hatching/pupation/emerging rates and sex‐specific survival), identifying MAL1 as a novel target for ...
Man‐Jin Li   +5 more
wiley   +1 more source

Development of Peptide Vaccines in Dengue [PDF]

open access: yesCurrent Pharmaceutical Design, 2018
Dengue is one of the most important arboviral infections worldwide, infecting up to 390 million people and causing 25,000 deaths annually. Although a licensed dengue vaccine is available, it is not efficacious against dengue serotypes that infect people living in South East Asia, where dengue is an endemic disease.
Reginald, Kavita   +3 more
openaire   +2 more sources

Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine.

open access: yesPLoS Pathogens, 2022
It has been estimated that more than 390 million people are infected with Dengue virus every year; around 96 millions of these infections result in clinical pathologies.
Abdullah M Izmirly   +13 more
doaj   +1 more source

Tick‐Borne Encephalitis (TBE) Vaccine in the National Immunisation Programme—For Whom, When and Where?

open access: yesActa Paediatrica, EarlyView.
ABSTRACT The incidence of Tick‐borne encephalitis (TBE) cases has increased. The presumed location of transmission of Tick‐borne encephalitis virus (TBEV) has been expanding increasingly in the western parts of Europe during the past decade. There has also been an increased incidence of surveillance‐reported TBE cases in southern Sweden and southern ...
H. H. Askling, D. Zavadska
wiley   +1 more source

Home - About - Disclaimer - Privacy